Clinical Trial Update: Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for dovitinib in adults with recurrent or progressive glioblastoma. The study is completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Dovitinib (dovitinib)

Snippet

Sponsor: Manmeet Ahluwalia, MD | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-08